HOME › DRUGS › RANIBIZUMAB-LEYK
ACTIVE SUBSTANCE / INN

RANIBIZUMAB-LEYK

Brand name(s): NUFYMCO
FDA LISTED
PRESCRIPTION
BLA761473
ACTIVE SUBSTANCE
Ranibizumab-Leyk
REGULATORS
FDA
SPONSORS / MAH
FORMYCON AG
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NUFYMCOBLA761473FORMYCON AGPrescription

FULL INTELLIGENCE ON RANIBIZUMAB-LEYK

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →